Business Context and Reporting Period
Company: Wearable Devices Ltd.
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: Six months ended June 30, 2025
Filing Date: September 9, 2025
Principal Executive Offices: 5 Ha-Tnufa Street, Yokne-am Illit, Israel
This filing incorporates by reference the Company's Unaudited Interim Condensed Consolidated Financial Statements, Management's Discussion and Analysis (MD&A), and a press release regarding First Half 2025 financial results.
Key Financial Metrics
The provided text serves as a cover document and does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the attached exhibits (Exhibit 99.1 and Exhibit 99.2) which are not included in the source text.
Equity Plan Update: On September 9, 2025, the Board of Directors approved an increase in ordinary shares reserved for issuance under the 2024 Global Equity Incentive Plan.
- Previous Reserve: 141,492 shares
- Increase Amount: 653,760 shares
- New Total Reserve: 795,252 shares
Material Changes
The primary material change disclosed in this specific text is the expansion of the share reserve for the 2024 Global Equity Incentive Plan. No other material changes regarding operations or financial position are detailed in the cover text.
Guidance, Outlook, and Risks
The filing references a press release (Exhibit 99.3) titled "Wearable Devices Announces First Half 2025 Financial Results," which likely contains management commentary, outlook, and risk factors. However, the specific content of this commentary is not present in the provided text.
Investor Verification Checklist
- Review Exhibit 99.1 for specific revenue, net income, and cash flow figures for the six months ended June 30, 2025.
- Examine Exhibit 99.2 (MD&A) for management's explanation of financial performance and liquidity position.
- Read Exhibit 99.3 (Press Release) for forward-looking guidance and any unusual items affecting the period.
- Verify the impact of the increased equity incentive plan share reserve (now 795,252 shares) on potential future dilution.